A Phase 1, Randomized, Double Blind, Placebo-Controlled, Single Dose Escalation Study In Japanese Healthy Subjects, And Open Label, Single Dose Study In Western Healthy Subjects To Investigate The Safety, Tolerability, And Pharmacokinetics of PF-04991532.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2011
At a glance
- Drugs PF 4991532 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 21 Sep 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 21 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.